Cellectar Biosciences Statistics
NASDAQ: CLRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.797-0.1036 (-11.50%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cellectar Biosciences by the numbers
Cellectar Biosciences has a market capitalization of $8.0 million based on 10.04M shares outstanding. With trailing EPS of $-2.34, Cellectar Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 46.2% below its 50-day average and 67.6% below its 200-day average.
Average daily trading volume is 97.96K shares, or about $78,073 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLRB valuation vs. peer median
| Metric | CLRB | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.00M | $8.19M | -2% |
| Avg. volume | 97.96K | 89.01K | +10% |
Peer median across 8 companies: DARE, PTN, PHIO, MBRX, QNTM, HIND, VTGN, LEXX.
Valuation
- Market cap
- $8.00M
- EPS (TTM)
- $-2.34
- Shares outstanding
- 10.04M
Price and trading
- Previous close
- 0.9006
- Open
- 0.90
- Day range
- 0.7596 – 0.90
- 52-week range
- 0.7596 – 4.70
- 52-week change
- -72.13%
- Beta
- —
- Volume
- 80.36K
- Average volume
- 97.96K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 8.00M
- Forward Pe
- -0.39
- Eps
- -2.34
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.70
- Week52 Low
- 0.76
- Avg Volume
- 97,959.00
- Shares Outstanding
- 10.04M
- Ma50
- 1.48
- Ma200
- 2.46
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -83.04%
- Pct From52w Low
- 4.92%